NuEyes NuLoupes Receive FDA Approval
NuEyes announced that its augmented reality loupes, NuLoupes, is now patent-pending and has received FDA approval.
NuEyes announced that its augmented reality loupes, NuLoupes, is now patent-pending and has received FDA approval.
As consolidation accelerates, the "Invisible DSO" model is gaining traction. Chip Fichtner explains how to secure back-office support and capital while retaining clinical autonomy—and how to avoid leaving millions on the table.